GlassScriptPhysician profile
Kochunni Mohan
NPI 1841269164
$3,150.28
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,491 · 2020: $898 · 2021: $252 · 2022: $199 · 2023: $173 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $650.48 | 2019-2023 | Lifevest |
| Amgen INC. | $347.62 | 2019-2021 | |
| Abbott Laboratories | $299.29 | 2019-2024 | Optis, Xience Skypoint, Coroflow |
| Janssen Pharmaceuticals, INC | $274.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $212.19 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $187.47 | 2019-2020 | |
| Shockwave Medical, INC | $166.59 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $156.19 | 2019-2022 | |
| Astellas Pharma US INC | $128.51 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $81.39 | 2019-2020 | |
| Edwards Lifesciences Corporation | $77.97 | 2020 | |
| Pfizer INC. | $77.12 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $67.17 | 2019-2023 | |
| Amarin Pharma, INC. | $65.74 | 2019-2020 | |
| Lundbeck LLC | $63.26 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.46 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $58.15 | 2019 | |
| Novo Nordisk INC | $41.92 | 2019-2020 | |
| Elutia, INC. | $33.07 | 2019 | |
| Boston Scientific Corporation | $26.27 | 2019 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.90 | 2019 | |
| Ekos Corporation | $14.73 | 2019 | |
| Esperion Therapeutics, INC. | $12.75 | 2020 | |
| Cardiovascular Systems INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kochunni Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.